Skip to main content
AddLife logo

AddLife — Investor Relations & Filings

Ticker · ALIF ISIN · SE0014401378 LEI · 5493005T3M7CD7XWE013 ST Wholesale and retail trade
Open in API
Filings indexed 294 across all filing types
Latest filing 2019-01-23 Share Issue/Capital Cha…
Country SE Sweden
Listing ST ALIF

About AddLife

https://www.add.life/

AddLife is a life science group that operates through a decentralized model, acquiring and developing market-leading companies in niche segments. The group consists of numerous independent subsidiaries that provide specialized products, services, and advisory support primarily to the healthcare and research sectors. Its offerings encompass a broad range of instruments, equipment, consumables, and advanced solutions for diagnostics, medical technology, and biomedical research and laboratory analysis. AddLife's business strategy focuses on combining the strength and resources of a large enterprise with the entrepreneurial drive and agility of its subsidiaries, fostering growth and innovation while preserving the unique culture of each acquired company.

Recent filings

Filing Released Lang Actions
AddLife offentliggör slutliga villkor för företrädesemission
Share Issue/Capital Change Classification · 99% confidence The document is a press release from AddLife AB announcing the final terms ('slutliga villkor') of a rights issue ('förtädesemission') intended to raise capital (approx. 500 MSEK) for growth and acquisitions. This action directly relates to the company's capital structure and fundraising activities. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it deals explicitly with a new share issue/fundraising effort. The document is short and serves as an announcement, but the core subject matter is financing, making CAP more specific than RPA or RNS.
2019-01-23 Swedish
AddLife announces the final terms of the rights issue
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces the 'final terms of the rights issue' and mentions raising capital to 'continue to pursue AddLife's growth strategy and to carry out additional strategic acquisitions.' A rights issue is a form of capital raising/financing activity. This directly aligns with the definition for Capital/Financing Update (CAP). The document is short and acts as a press release announcing the final terms, not the full prospectus, making CAP more appropriate than a general RNS.
2019-01-23 English
Extra general meeting of shareholders in AddLife AB (publ)
Capital/Financing Update Classification · 98% confidence The document details resolutions passed at an 'Extra general meeting of shareholders' concerning an 'issue in kind' and a 'preferential rights issue' intended to settle part of an acquisition price and raise capital for growth. This directly relates to changes in the company's capital structure and financing activities. While it mentions a general meeting, the core subject is the capital action itself, not just the voting results (DVA) or general AGM presentation (AGM-R). The most fitting category is Capital/Financing Update (CAP), as it describes the terms and purpose of a rights issue and share capital increase.
2018-12-20 English
Kommuniké från extra bolagsstämma i AddLife AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kommuniké från extra bolagsstämma i AddLife AB (publ)" (Communiqué from the Extraordinary General Meeting in AddLife AB (publ)). It details decisions made at the EGM on December 20, 2018, specifically concerning an asset transfer issue (apportemission) and a rights issue (förtädesemission) related to an acquisition (Biomedica). While it relates to a general meeting, the core content is about capital structure changes (issuing new shares for acquisition settlement and fundraising). This strongly points towards a Capital/Financing Update (CAP). Although it mentions the EGM, the primary focus is the financial transaction details, not the voting results (DVA) or general AGM materials (AGM-R). Given the explicit details about share issuance, subscription prices, and capital raising motives, CAP is the most appropriate classification.
2018-12-20 Swedish
AddLife signs agreement with Wellspect HealthCare on acquisition of business in surgery and respiration
M&A Activity Classification · 99% confidence The document announces a specific corporate action: AddLife signing an agreement to acquire a business segment from Wellspect HealthCare for EUR 18 million. This is a material event related to corporate structure and growth strategy, but it does not fit the definitions for a standard financial report (10-K, IR, ER), a management change (MANG), or a dividend announcement (DIV). It is a significant transaction announcement. The closest fitting category among the provided options for a major corporate transaction like an acquisition or takeover proposal is 'M&A Activity' (TAR). Since the document is a formal press release detailing the terms and expected closing date of an acquisition, TAR is the most appropriate classification.
2018-12-19 English
AddLife tecknar avtal med Wellspect HealthCare om förvärv av verksamhet inom kirurgi och respiration
M&A Activity Classification · 99% confidence The document text is a press release dated December 19, 2018, announcing that AddLife has signed an agreement to acquire a business unit from Wellspect HealthCare. It details the transaction value (18 million EUR), the acquired assets (niche products, rights, customer agreements), and the expected closing date (Q1 2019). This type of announcement, detailing a significant corporate transaction like an acquisition, falls under the category of M&A Activity (TAR). It is not a full financial report (10-K or IR), an earnings release (ER), or a general regulatory filing (RNS), but specifically concerns a takeover/merger proposal/activity.
2018-12-19 Swedish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.